NIPH Clinical Trials Search

JRCT ID: jRCTs031230071

Registered date:15/05/2023

A Chemical peeling safety and efficacy test

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedhealthy adult
Date of first enrollment18/05/2023
Target sample size25
Countries of recruitment
Study typeInterventional
Intervention(s)chemical peeling


Primary OutcomeSafety assessment
Secondary OutcomeInstrumental skin measurement/Stratum Corneum examination/ visual observation/ photograph evaluation /skein tone color scale/Microscope observation/Satisfaction survey after using test product

Key inclusion & exclusion criteria

Age minimum> 20age old
Age maximum< 70age old
Include criteria1)Those who have expressed their willingness to participate in the study, understood the explanation, and agreed in writing to participate in the study 2)Healthy Japanese women between the ages of 20 and 70 who wish to improve solar lentigines, freckle spots, chloasma, so-called dullness, and who do not meet the exclusion criteria, regardless of the presence or absence of diseases such as pigment spots 3)Those who can fill in documents such as consent forms, questionnaires, usage diaries, etc. 4)Those who can come to the facility on the designated observation day
Exclude criteria1)Subjects who are likely to be exposed to sunlight during the test period (daytime sports, etc.) 2)Subjects who are strongly aware of sensitive skin 3)Those who have experienced allergic symptoms due to cosmetics etc 4)Subjects with skin symptoms such as atopic dermatitis, seborrheic eczema, and vitiligo, and those with a history of them 5)Subjects with coagulation disorder, immune disorder, facial herpes, severe acne, eczema, etc. 6)Those with severe hay fever 7)Subjects with a history of serious liver disorder, renal disorder, or myocardial infarction 8)Those who are pregnant or during the study period, those who may become pregnant, and those who are breastfeeding 9)Subjects who received facial, high-frequency treatment, injection treatment, etc. within 3 months from the start of the study 10)Those who participated in other clinical trials, research, etc. within 6 months of the start of the trial 11)Those who plan to participate in other clinical trials during the trial period 12)Subjects with skin symptoms not suitable for chemical peeling on the face 13)In addition, those who have symptoms that should be excluded by the attending physician or responsible physician

Related Information


Public contact
Name Masahiro Kuramochi
Address Sankyo NishiShinjuku-Buidling 4F,4-2-18 Nishi-Shinjuku,Shinjuku-ku,Tokyo Tokyo Japan 160-0023
Telephone +81-3-5354-7388
Affiliation Beauty and Health Research,Inc Medical Research Department
Scientific contact
Name Toshitatsu Nogita
Address Hakuaido-Building 4F,1-18-7,Nishi-Shinjuku,Shinjuku-ku,Tokyo Tokyo Japan 160-0023
Telephone +81-3-3343-4103
Affiliation The Shinkohkai Medical corporation Shinjuku Minamiguchi Dermatology